Literature DB >> 11157506

Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hématologique.

H Avet-Loiseau1, A Daviet, C Brigaudeau, E Callet-Bauchu, C Terré, M Lafage-Pochitaloff, F Désangles, S Ramond, P Talmant, R Bataille.   

Abstract

Primary plasma cell leukemia (PCL) is a rare plasma cell malignancy. Consequently, few large reports have been published. Presented is a cytogenetic analysis of 40 patients with primary PCL compared with 247 newly diagnosed patients with stage III multiple myeloma (MM). Cytogenetic abnormalities were observed in 23 of 34 patients, with usually complex hypodiploid or pseudodiploid karyotypes. Analysis of rearrangements of the 14q32 region revealed significant differences with high cell mass MM-a higher incidence of t(11;14) (33% vs 16%; P <.025) and of t(14;16) (13% vs 1%; P <.002) though incidences of t(4;14) were identical and a higher incidence of monosomy 13 (68% vs 42%; P =.005). Hypodiploid karyotypes and monosomy 13 may explain, at least in part, the poorer prognosis of primary PCL. In contrast, significantly longer survival was observed in patients displaying t(11;14) in comparison with those lacking this translocation (P =.001).

Entities:  

Mesh:

Year:  2001        PMID: 11157506     DOI: 10.1182/blood.v97.3.822

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Plasma cell leukemia.

Authors:  Moria A Gertz; Francis K Buadi
Journal:  Haematologica       Date:  2010-05       Impact factor: 9.941

2.  Epstein-Barr virus-positive diffuse large B-cell lymphoma carrying a t(9;14)(p13;q32) translocation.

Authors:  Hitoshi Ohno; Momoko Nishikori; Hironori Haga; Kotaro Isoda
Journal:  Int J Hematol       Date:  2009-05-12       Impact factor: 2.490

3.  Clinico-pathological spectrum of primary plasma cell leukemia diagnosed at a tertiary care centre in South India over 5 year period.

Authors:  Rakhee Kar; Sarah Grace Priyadarshini; M Niraimathi; Debdatta Basu; Bhawana Ashok Badhe
Journal:  Indian J Hematol Blood Transfus       Date:  2012-02-01       Impact factor: 0.900

4.  Thirty patients with primary plasma cell leukemia: a single center experience.

Authors:  Milica Colović; Gradimir Janković; Nada Suvajdzić; Natasa Milić; Vesna Dordević; Snezana Janković
Journal:  Med Oncol       Date:  2007-10-10       Impact factor: 3.064

Review 5.  How I treat plasma cell leukemia.

Authors:  Niels W C J van de Donk; Henk M Lokhorst; Kenneth C Anderson; Paul G Richardson
Journal:  Blood       Date:  2012-07-26       Impact factor: 22.113

6.  Primary plasma cell leukemia and autologous stem cell transplantation.

Authors:  Mary B Drake; Simona Iacobelli; Anja van Biezen; Curly Morris; Jane F Apperley; Dietger Niederwieser; Bo Björkstrand; Gösta Gahrton
Journal:  Haematologica       Date:  2010-05       Impact factor: 9.941

7.  Trends in survival of patients with primary plasma cell leukemia: a population-based analysis.

Authors:  Wilson I Gonsalves; S Vincent Rajkumar; Ronald S Go; Angela Dispenzieri; Vinay Gupta; Preet P Singh; Francis K Buadi; Martha Q Lacy; Prashant Kapoor; David Dingli; John A Lust; Steven R Zeldenrust; Suzanne R Hayman; Robert A Kyle; Morie A Gertz; Shaji K Kumar
Journal:  Blood       Date:  2014-06-23       Impact factor: 22.113

8.  Complex IGH rearrangements in multiple myeloma: Frequent detection discrepancies among three different probe sets.

Authors:  Gina Y Kim; Ana Gabrea; Yulia N Demchenko; Leif Bergsagel; Anna V Roschke; W Michael Kuehl
Journal:  Genes Chromosomes Cancer       Date:  2014-03-03       Impact factor: 5.006

9.  Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma.

Authors:  P Leif Bergsagel; W Michael Kuehl; Fenghuang Zhan; Jeffrey Sawyer; Bart Barlogie; John Shaughnessy
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

10.  Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors.

Authors:  Ana Gabrea; Maria Luisa Martelli; Ying Qi; Anna Roschke; Bart Barlogie; John D Shaughnessy; Jeffrey R Sawyer; W Michael Kuehl
Journal:  Genes Chromosomes Cancer       Date:  2008-07       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.